Leading oxygen concentrator manufacturers Yuwell Medical and Inogen have announced an investment tie up to advance their medical device and respiratory businesses.
Yuwell, through its whole-owned subsidiary Yuwell (Hong Kong) Holdings, has agreed to invest approximately $27.2m in Inogen, representing 9.9% of the outstanding shares of Inogen’s common stock.
The memorandum, announced at Arab Health in Dubai, unites two of the major players in the China and US respiratory health sectors.
Both companies agree to carry out in-depth strategic cooperation based on business synergy in international distribution business, trademark licensing and distribution business, joint research and development, and supply chain optimisation.
... to continue reading you must be subscribed
